Proteome Sciences

Proteome Sciences is a London (UK) and Frankfurt (Germany) based SME with expertise in proteomics and biomarker research. We have discovered and patented a large number of novel protein biomarkers for diagnosis, prognosis and treatment of key human diseases including neurodegenerative disorders, cancer, stroke etc. and provide protein biomarker services to pharmaceutical and diagnostics companies. Our PS Biomarker Services for discovery and validation of biomarkers includes gel-based and gel-free separations linked to tandem mass spectrometry. We use proprietary isobaric tagging for higher throughput and better precision in biomarker discovery. We have also developed identical isotopic tags for rapid development of biomarker validation assays using isotope dilution mass spectrometry and Selected Reaction Monitoring (SRM). Such MS-based assays are rapid to develop compared to immunoassay and have potential for high rates of multiplexing. Proteome Sciences also provides analysis of post-translational modifications (PTM) and assays for such PTMs. We have wide experience across the life sciences sector working with many different human and animal sample types including blood plasma, CSF, solid tissues, cell culture material etc. As a reflection of the quality of our approach, the purpose built, state-of-the-art research facility in Frankfurt is certified to ISO 9001:2008.
Type
Public
HQ
Cobham, GB
Size (employees)
35 (est)-2%
Proteome Sciences is headquartered in Cobham, GB

Proteome Sciences Office Locations

Proteome Sciences has an office in Cobham
Cobham, GB (HQ)
Downside Bridge Rd Covenham House

Proteome Sciences Data and Metrics

Proteome Sciences Financial Metrics

Proteome Sciences's revenue was reported to be £2.7 m in FY, 2016 which is a 46% increase from the previous period.
GBP

Revenue (FY, 2016)

2.7 m

Revenue growth (FY, 2015 - FY, 2016), %

46%

Gross profit (FY, 2016)

1.5 m

Gross profit margin (FY, 2016), %

56%

Net income (FY, 2016)

(2.3 m)

Market capitalization (22-Sep-2017)

10.5 m

Closing share price (22-Sep-2017)

0

Cash (31-Dec-2016)

2.9 m
Proteome Sciences's current market capitalization is £10.5 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 m1.6 m1.9 m2.7 m

Revenue growth, %

(27%)21%46%

Cost of goods sold

592.7 k605 k791 k1.2 m

Gross profit

1.5 m956 k1.1 m1.5 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash

600.3 k1.9 m1.8 m2.9 m

Accounts Receivable

89.3 k207 k364 k399 k

Current Assets

1.8 m3.3 m3.4 m4.9 m

PP&E

1.1 m788 k1.1 m592 k
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(2.8 m)(3.3 m)(2.4 m)(2 m)

Cash From Financing Activities

2.6 m4.8 m2.3 m2.9 m

Income Taxes Paid

447 k661 k608 k663 k
Y, 2016

Financial Leverage

-51.3 x
Show all financial metrics

Proteome Sciences Market Value History

Traffic Overview of Proteome Sciences

Proteome Sciences Online and Social Media Presence

Proteome Sciences Company Life and Culture

You may also be interested in